Erratum: Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy (Cancer (2012) 118 (4053-4062))

G. Zafarana, A. S. Ishkanian, C. A. Malloff, J. A. Locke, J. Sykes, J. Thoms, W. L. Lam, J. A. Squire, M. Yoshimoto, V. R. Ramnarine, A. Meng, O. Ahmed, I. Jurisca, M. Milosevic, M. Pintilie, T. Van Der Kwast, R. G. Bristow

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalCancer
Volume120
Issue number15
DOIs
StatePublished - Aug 1 2014

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Zafarana, G., Ishkanian, A. S., Malloff, C. A., Locke, J. A., Sykes, J., Thoms, J., Lam, W. L., Squire, J. A., Yoshimoto, M., Ramnarine, V. R., Meng, A., Ahmed, O., Jurisca, I., Milosevic, M., Pintilie, M., Van Der Kwast, T., & Bristow, R. G. (2014). Erratum: Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy (Cancer (2012) 118 (4053-4062)). Cancer, 120(15). https://doi.org/10.1002/cncr.28759